CIK 0001177648 · Non-accelerated filer<br>Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 043205099
- Phone
- 617 607 0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-25 | Capps Kathleen S. See Remarks | Grant or award | +3,163 | 8,992 | ||
| 2025-11-25 | Capps Kathleen S. See Remarks | Grant or award · Stock Option (right to buy) | +6,325 | 6,325 | ||
| 2025-11-25 | Trout Harry R. III See Remarks | Grant or award | +6,463 | 17,375 | ||
| 2025-11-25 | Trout Harry R. III See Remarks | Grant or award · Stock Option (right to buy) | +12,925 | 12,925 | ||
| 2025-11-25 | Luu Brendan Chief Business Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-11-25 | Kieffer Tara Lynn Chief Product Strategy Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-11-25 | Kowalsky Matthew Paul Chief Legal Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-11-25 | Rottinghaus Scott T. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2025-11-25 | Or Yat Sun Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2025-11-25 | Luly Jay R. President and CEO | Grant or award · Stock Option (right to buy) | +310,000 | 310,000 | ||
| 2025-08-08 | Rottinghaus Scott T. Chief Medical Officer | Shares withheld for taxes | −2,217 | $6.99 | $15K | 22,590 |
| 2025-03-13 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | ||
| 2025-03-13 | Russell Lesley Director | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | ||
| 2025-03-13 | Peterson Kristine Director | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | ||
| 2025-03-13 | Hata Yujiro S Director | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | ||
| 2025-03-13 | FOLETTA MARK G Director | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | ||
| 2025-03-13 | CARTER BRUCE L A Director | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | ||
| 2025-02-12 | Luu Brendan Chief Business Officer | Grant or award | +7,500 | 43,547 | ||
| 2025-02-12 | Luu Brendan Chief Business Officer | Shares withheld for taxes | −3,326 | $5.59 | $19K | 40,221 |
| 2025-02-12 | Kieffer Tara Lynn Chief Product Strategy Officer | Grant or award | +7,500 | 36,805 |
Page 3 of 7 · 135 trades